Loading company…
Boston-based healthcare technology company using AI and real-world data to support research and personalized medicine.
OM1, Inc., founded in 2015 and based in Boston, US, uses artificial intelligence and real-world data to support healthcare research and personalized medicine. Its products include PhenOM and digital phenotyping tools built on a network covering over 300 million lives. The July 2021 Series D round raised USD 85.00 mn, co-led by Breyer Capital, D1 Capital Partners and Kaiser Permanente Ventures. Rich Gliklich is founder and CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in